Autonomic dysfunction is linked to sudden death regardless of the presence of structural heart disease. The pathway from autonomic dysfunction to sudden death is not fully understood, but myocardial sympathetic stimulation leading to arrhythmia and/or cardiac fibrosis might play a role. Our goal was to evaluate cardiac stiffness by echocardiography and its association with clinical, structural, and autonomic variables in people with epilepsy (PWE) compared to healthy controls.
| INTRODUCTION
The interaction between the autonomic nervous and cardiovascular systems is complex. Autonomic dysfunction is linked to sudden death regardless of the presence of structural heart disease. 1 People with epilepsy (PWE) have an increased risk of sudden unexpected death in epilepsy (SUDEP) compared to the general population, and SUDEP Interictal autonomic dysfunction has been associated with epilepsy. 3, 4 The pathway from autonomic dysfunction to sudden death is not fully understood. Myocardial sympathetic stimulation acutely leading to arrhythmia and/or chronically leading to cardiac fibrosis might play a role. Echocardiography and treadmill testing are widely used in cardiology to analyze structural and functional heart changes and also autonomic response to exercise; these factors have impact on outcomes such as sudden and all-cause death. 5 Subtle changes in cardiac stiffness are measurable by echocardiography 6, 7 and have also been described in PWE as we discussed in a previous paper. 8 Our present goal was to evaluate cardiac stiffness by echocardiography, a noninvasive marker of cardiac fibrosis, and its association with clinical, structural, and autonomic variables in PWE compared to healthy controls. Our hypothesis was that subtle heart abnormalities related to cardiac stiffness were more prevalent in TLE patients, compared to controls, and could be related to autonomic dysfunction and epilepsy-related variables.
| MATERIALS AND METHODS

| Patients and controls
The enrollment criteria were described previously. 3 Briefly, we included patients with a definite diagnosis of temporal lobe epilepsy (TLE) followed at the Comprehensive Epilepsy Center at the University Hospital of Santa Catarina, Brazil, between July 2015 and July 2016. 3 Epilepsy was diagnosed according to International League Against Epilepsy (ILAE) criteria and endorsed by electroencephalography and neuroimaging. 9 All patients had focal seizures with impairment of awareness. Five patients had additional focal seizures evolving to bilateral tonic-clonic seizures. 9 Antiepileptic drug (AED) regimen, the defined daily dose (DDD), the prescribed daily dose (PDD), and the ratio of PDD/DDD were assessed. 10 The control group was composed of healthy individuals matched with cases by sex, age, and body mass index (BMI).
Patients and controls with neurovascular disease, peripheral artery disease, or any known cardiovascular disease, such as ischemic heart disease, moderate or severe valve stenosis or insufficiency, congenital or arrhythmic heart disease, or more than mild hypertension (≥160 9 100 mm Hg) were excluded.
| Test procedures
All individuals had treadmill testing (Super ATL, Imbramed, Brazil) and transthoracic echocardiography (General Electric Medical Systems, Vivid S6, Tirat Carmel, Israel), equipped with a M4S-RS 1.5-3.6 MHz matrix array transducer.
Examinations were performed during an interictal period of at least 24 hours by a board-certified cardiologist (G.L.F.), blinded to all clinical and demographic data, according to current guidelines. 11 
| Treadmill testing
Exercise testing was performed until exhaustion. Observation was extended until 5 minutes in the recovery period, or longer if necessary. Clinical variables such as chest pain, electrocardiographic variables such as arrhythmia, and autonomic/hemodynamic variables such as blood pressure response during and after exercise; heart rate at rest, at peak effort, and after 1 minute in the recovery period; duration of exercise; and metabolic equivalent of task (MET) achieved, were assessed.
Chronotropic incompetence, which can be defined as the inability of the heart to increase its rate in response to activity, was also analyzed. Chronotropic incompetence occurs when there is failure to achieve 85% of maximal heart rate predicted by age, calculated as 220 À age (Karnoven's formula) or 80% of the chronotropic index: (peak heart rate À resting heart rate)/(220 À age À resting heart rate). 12 
| Echocardiography
A full echocardiography examination, measuring cardiac size and function (systolic and diastolic) was performed as described earlier. 8 Noninvasive estimation of the left ventricular end-diastolic pressure-volume relationship (LVEDPVR) and stiffness constant, b, was measured by the method described by Klotz et al. 6 Briefly, LVEDPVR can be predicted by calculating the volume (LVEDV) at which pressure is 0 mm Hg {V 0 = LVEDV 9 [0.6-(0.006 9 DP)]} and volume at which pressure is equal to 30 mm Hg
]. DP (left ventricle diastolic filling pressure) can be estimated as 4.4 + (0.85 9 E/e 0 ). LVEDPVR can be estimated as
where EDP is end-diastolic pressure and EDV is enddiastolic volume.
| Statistical analysis
Statistical analysis was performed using IBM (Armonk, NY, USA) SPSS software package for Windows, version 17. Continuous variables were expressed as mean AE standard deviation (SD) and categorical variables were expressed as percentage of the total group. Normality of distribution was e86 | assessed by the Kolmogorov-Smirnoff test. Two-tailed Student's t-test was used to compare quantitative variables and Fisher's exact (2 9 2 contingency tables) or Pearson's chisquare (3 9 2 contingency tables) tests were used to compare categorical variables and occurrence frequency. Independent predictors of stiffness constant b among demographic, clinical, echocardiographic, and treadmill test data were analyzed using multiple linear regression. To accomplish this, variables identified by previous univariate analysis with a P-value <.2 were retained for the final model.
Patients and controls were also categorized according to the stiffness level in higher level (including the 20% individuals with higher stiffness scores) or lower level of stiffness (the remaining individuals of our sample). Binary regression analysis was done to determine the association between the diagnosis of epilepsy or not (controls) and higher levels of stiffness. The level of association was determined by the odds ratio (OR; confidence interval [CI] 95%). A P-value of ≤.05 was considered statistically significant.
| Ethical approval
This study was conducted in accordance to the Code of Ethics of the World Medical Association and the Uniform Requirements for Manuscripts Submitted to Biomedical Journal. Institutional review boards and local ethics committees (CEPSH/UFSC) approved the study protocol and informed consent, which was signed by all subjects who voluntarily agreed to participate in the study.
| RESULTS
We consecutively enrolled 60 subjects (30 PWE and 30 controls). PWE had epilepsy for 22.5 AE 10.7 years (age of onset 15.2 AE 10.1 years). Hippocampal sclerosis was present in 58.1% of patients (bilateral lesion was found in 13.3%, whereas right and left lesions occurred in 43.3%, respectively). Demographic and clinical variables were described previously elsewhere. Table 2 . Autonomic parameters such as the difference of peak and resting heart rate, percentage achieved of the predicted peak heart rate and chronotropic index, explained 52% of stiffness variation (Model 3 in Table 2 ). The inclusion of carbamazepine treatment alone (Model 2 in Table 2 ) or in combination with polytherapy with AEDs (Model 1 in Table 2 ) explained 6% and 12% of the stiffness variation, respectively. When we looked for individuals with stiffness constant b > 5.98 (20% higher stiffness constant b), 9 (15%) were patients with TLE and 2 were controls (3.3%). Therefore, TLE was 6 times more associated with the highest stiffness constant b than controls (OR 6.0, 95% CI 1.05-61.03, P = .04).
| DISCUSSION
We found an association between autonomic dysfunction and left ventricle stiffness. Autonomic dysfunction is prevalent in PWE 4 and also in patients with heart failure with preserved ejection fraction (HFpEF). 4 We recently demonstrated that the percentage achieved of the predicted peak heart rate and chronotropic index was related to age of onset of epilepsy and number of monthly bilateral tonicclonic seizures. 3 In a rat model, autonomic dysfunction, with increased sympathetic drive and lower parasympathetic activity, was related to modification of the calcium handling in cardiac myocytes, leading to increased stiffness. 13 Acute sympathetic stimulus can cause myocardial damage leading to neurogenic stunned myocardium or Takotsubo cardiomyopathy.
14 Microvascular spasm leading to ischemia or direct catecholamine toxicity leading to electrolyte disturbances such as myocardial calcium overload FIALHO ET AL.
and contraction band necrosis are potential mechanisms. 14, 15 Ion channel remodeling after status epilepticus has been shown in a murine model, which increased the risk of lethal arrhythmia for 12-14 days after the convulsive event. 16 Chronic and repeated sympathetic bursts, as seen in PWE, might cause subtle cardiovascular changes, not necessarily leading to gross anatomic or structural changes 17 inducing myofilament damage, extracellular matrix Associations between categorical clinical variables (independent variables) and the mean and standard deviation (SD) of stiffness coefficient (dependent variable) were determined by Student's t-test or analysis of variance (ANOVA).
Variables showing a level of association for "P" <.20 were included in the multiple linear regression analysis (see Table 2 ). | deposition, fibrosis, and stiffness. Fibrosis per se is related to worse cardiovascular outcomes and sudden death as seen in different populations with heart failure, cardiomyopathy, and ischemic heart disease. 18 To the best of our knowledge, our group was the first to report increased stiffness in PWE. 8 Increased stiffness is related to higher left ventricle filling pressure presented as E/(average e 0 ) ratio, greater left atrial volume, and right ventricle dimensions. Kasner et al 7 studying patients with heart failure with preserved ejection fraction, found a mean value of 5.96 for the stiffness constant b in HFpEF patients and 5.86 for controls. In that study, the stiffness constant b measured by echocardiography had a good correlation to stiffness invasively measured by conductance catheter and N-terminal pro-brain natriuretic peptide levels. 7 Our study has limitations that need to be addressed. First, the number of patients included is limited and restricted to TLE patients, which may result in false-negative results. Second, we did not have access to global myocardial strain, an echocardiographic measure of myocardial deformation that could have added some information about subtle systolic and diastolic function.
In conclusion, we studied a young population of individuals with TLE with a low prevalence of traditional cardiovascular risk factors, and found increased sudden death risk markers, such as autonomic dysfunction and greater myocardial stiffness compared to healthy controls. 
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T A B L E 2 Independent predictors of cardiac stiffness (b) from patients with epilepsy determined by multiple linear regression analysis Multiple linear regression models that better explain the cardiac stiffness (b) variation of patients with TLE.
a Predicted maximal heart rate = 220 À age by Karnoven's formula. b (Peak heart rate À resting heart rate)/(220 À age À resting heart rate).
